A Guernsey family's desperate struggle for their baby's health has sparked a crucial conversation about medication access and affordability.
A Mother's Plea: Fighting for Arnold's Health
Kiely Luscombe, a mother from Guernsey, shares a heart-wrenching story of her nine-month-old son, Arnold, who battles dysmotility and hypermotility, disorders affecting his digestive system. The family's journey began with Arnold's constant pain and vomiting, leading to a rushed trip to Southampton Hospital for treatment.
The prescribed medication, Mebeverine, brought temporary relief but came with a hefty price tag. Arnold's oral solution, typically for children aged 3 and above, costs a staggering £312.70 per bottle, lasting only a month. This expense is not covered by the States of Guernsey, leaving the family in a financial dilemma.
The Impact: A Family's Sacrifice
Luscombe and her partner have sold their belongings to afford Arnold's medication, feeling "lost" and "let down" by the system. With four children between them, the financial burden is overwhelming.
"We're looking at £3,500 a year, and it's just not feasible," Luscombe explains. Despite advice to reduce dosages, Arnold's health deteriorated further.
"His tummy swelled, he couldn't eat or go to the toilet. I don't understand why it should cost so much for him to have a decent life," she adds.
A Systemic Issue: The Need for Support
Teena Bhogal, Chief Pharmacist, acknowledges the family's struggle, stating, "We want to ensure families don't feel unsupported." The Prescribing Support Unit (PSU) offers guidance and explores alternatives, but so far, no requests for this specific medication have been received.
Controversy and Comment: Your Thoughts?
This story raises questions: Should essential medications be more accessible and affordable? How can we ensure families like Arnold's receive the support they need? Share your thoughts and experiences in the comments.
Let's spark a conversation to bring awareness and potential solutions to this critical issue.
